Search

Search Constraints

You searched for: Author/Creator Wind-Rotolo, Megan

Search Results

1. 1504: IMMUNE CHECKPOINT INHIBITORS IN SEPSIS. (January 2018)

2. Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Issue 3 (18th March 2022)

3. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014)

4. Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma. Issue 1 (11th December 2019)

5. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Issue 1 (January 2022)

6. Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Issue 3 (3rd March 2021)

9. The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies. (November 2018)